2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Design of a Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa for Parkinson’s Disease (PD) Patients Experiencing Motor Fluctuations

P. LeWitt, R. Gendreau, J. Meckler, N. Navon (West Bloomfield, MI, USA)
Determinants of absence of dyskinesia in Parkinson’s disease patients with treatment beyond 10 years

R. Ou, Y. Wu, Q. Wei, X. Yuan, Y. Hou, H. Liu, L. Zhang, Y. Chen, B. Cao, X. Chen, H. Shang (Chengdu, China)
Determinants of Bed Mobility Proficiency in Patients with Parkinson’s Disease: A Pilot Study

S. Taniguchi, N. D’Cruz, T. Osaki, M. Nakagoshi, A. Nieuwboer, T. Shimokawa (Kobe, Japan)
Determinates and predictors of quality of life improvements after subthalamic deep brain stimulation in Parkinson’s disease

F.T. Liu, L.Q. Lang, Y.J. Yang, J. Zhao, J. Wang, J.J. Wu (Shanghai, China)
Determination of falling direction in Parkinson’s disease patients using a wearable sensor

Y. Okuma, H. Mitoma (Izunokuni, Japan)
Determining the effect of the HNMT, STK39 and NMD3 polymorphisms on the incidence of Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese populations

Y.P. Chen, B. Cao, R.W. Ou, Q.Q. Wei, X.P. Chen, B. Zhao, Y. Wu, W. Song, H.F. Shang (Chengdu, People’s Republic of China)
Developing a Self-Administered Instrumented Motor Exam for Home-based Parkinson’s Disease Assessment Using Wearable Sensors

S. Patel, C. Demanuele, B. Ho, P. Wacnik, H. Zhang, T. Kangarloo, V. Ramos, S. Amato, D. Volfson, P. Bergethon, M. Erb (Cambridge, MA, USA)
Development of a biomarker for Parkinson’s disease by measuring alpha-synuclein oligomers in cerebrospinal fluid with ultrasonication-induced amyloid fibril formation

K. Kakuda, K. Ikenaka, K. Araki, Y. Kajiyama, M. So, H. Hayakawa, T. Omichi, K. Baba, K. Konaka, T. Tokuda, Y. Goto, H. Mochizuki (Suita, Japan)
Development of a system to measure the kinetic responses of parkinsonian animal model

G.T. Kim (InCheon, Republic of Korea)
Development of anti-amyloid drugs for Parkinson’s disease by combination screening of high-throughput in vitro assay and phenotype-based C. elegans system

K. Ikenaka, K. Araki, S. Sonoda, T. Takeuchi, Y. Nagai, Y. Goto, H. Mochizuki (Suita, Japan)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z